Celularity Inc (CELU) Stock: What Does the Chart Say Wednesday?

Celularity Inc (CELU) stock is up 34.78% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Celularity Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CELU!

See Full CELU Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With CELU Stock Today?

Celularity Inc (CELU) stock is trading at $0.31 as of 1:46 PM on Wednesday, Oct 18, a drop of -$0.01, or -3.74% from the previous closing price of $0.32. The stock has traded between $0.22 and $0.35 so far today. Volume today is elevated. So far 1,182,789 shares have traded compared to average volume of 595,641 shares.

More About Celularity Inc

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. Click Here to get the full Stock Report for Celularity Inc stock.